Press Room

The California Senate Health Committee voted to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. 

State Senator Monique Limón introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient.  ACS CAN and the University of California have teamed up to sponsor this important step in ensuring cancer patients have access to precision medicine.

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Kimberly Hughes